Life  ERLC Actions  Policy Statement  Abortion  Sanctity of Life

ERLC Celebrates Fifth Circuit Decision Blocking FDA Mail-Order Abortion Drug

Blocking FDA Mail-Order Abortion Drug

Today, the U.S. Fifth Circuit Court of Appeals released a consequential decision blocking the Biden administration’s mail-order abortion policy. Because of this ruling, mail-order abortions will be halted, effective immediately. The ruling temporarily reinstates the in-person dispensing requirement for mifepristone, the chemical abortion pill. As a result, women will be protected and countless preborn lives will be saved. In Louisiana alone, the state estimates 1,000 preborn lives are lost each month to these pills.

The Fifth Circuit has affirmed what the State of Louisiana has courageously and consistently articulated: The federal government cannot interfere with the protections offered to women and preborn children by pro-life states who seek to combat mail-order abortion drugs, a practice which violates those very protections. It’s past time for the FDA to reverse harmful, permissive policies, and, instead, to reinstate protections against the chemical abortion pill.

As the ruling states, “The public interest is not served by perpetuating a medical practice whose safety the agency admits was inadequately studied. Indeed, the public interest demands the opposite.”

The ERLC has persistently advocated for the reinstatement of guardrails like the in-person dispensing requirement, at a bare minimum, even as we work toward the end of abortion. This victory can be celebrated as we continue to advocate for the permanent eradication of the chemical abortion pill nationwide.

Blocking FDA Mail-Order Abortion Drug


Related Policies
and
Supreme Court Cases

Ending the Proliferation of Chemical Abortions

ERLC urges Congress to oppose the proliferation of chemical abortions and pass legislation such as the SAVE Moms and Babies Act.

Southern Baptists affirm that every human is created in the image of God. As...

Read More
State of Louisiana v. Food & Drug Administration

State of Louisiana v. Food & Drug Administration is about the FDA’s 2023 approval of mail order abortion drugs. Louisiana successfully...

State of Louisiana v. Food & Drug Administration is about the FDA’s 2023 approval...

Read More

Related Content

federal funding for physician-assisted suicide

ERLC submits public comments opposing federal funding for physician-assisted suicide

Letter to Secretary Robert F. Kennedy Jr.

Today, Dr. Evan Lenow filed a public comment letter in response to a federal...

Read More

ERLC asks FDA head for immediate action on abortion pill

Letter to Acting Commissioner Kyle A. Diamantas

On June 1, ERLC President Dr. Evan Lenow sent a letter to Acting Commissioner...

Read More

ERLC files brief opposing Biden administration’s pro-abortion rule for pregnant workers

USCCB v. EEOC

On May 26, the ERLC joined other pro-life advocates in filing an amicus brief...

Read More
abortion pill case

Update: Supreme Court Shamefully Reinstates Access to Mail-Order Abortions, Sends Case Back to Fifth Circuit

Sadly, today, the United States Supreme Court granted a request from chemical abortion drug...

Read More
defunding abortion providers

ERLC joins coalition letter urging congressional support for defunding abortion providers

Letter to House and Senate Leadership

The ERLC joined pro-life coalition partners in a letter to congressional leadership urging an...

Read More
National Foster Care Month

ERLC advocates for foster care families and children, highlighted in recent DOJ report

May is National Foster Care Month, a time to pray for the roughly 300,000...

Read More